Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer

BACKGROUND: Regorafenib is a multi-targeted tyrosine kinase inhibitor approved for use in refractory colorectal cancer. We report the first case of seizures secondary to acute liver failure, shortly after initiation of regorafenib in a patient with advanced rectal carcinoma. CASE PRESENTATION: A 64 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Raissouni, Soundouss, Quraishi, Zarqa, Al-ghamdi, Mohammed, Monzon, Jose, Tang, Patricia, Vickers, Michael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593199/
https://www.ncbi.nlm.nih.gov/pubmed/26438070
http://dx.doi.org/10.1186/s13104-015-1502-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593199/
https://www.ncbi.nlm.nih.gov/pubmed/26438070
http://dx.doi.org/10.1186/s13104-015-1502-4

Ejemplares similares